P. Krief

发表

GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways

G. Mufti, V. Vanneaux, L. Sarda-Mantel, 2016, Journal of Hematology & Oncology.

BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells.

D. Felsher, M. Konopleva, M. Andreeff, 2013, Blood.

Niclas mouse model of AML by targeting primitive LSK and progenitor cells BCL-2 inhibition with ABT-737 prolongs survival in an NRAS / BCL-2

D. Felsher, M. Konopleva, M. Andreeff, 2013 .

Screening Monoclonal Antibodies against Cell‐Surface Antigens High Frequency of Natural Antibodies

J. Perrot, C. Boucheix, P. Benoit, 1986, Scandinavian journal of immunology.

pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice

V. Mathews, P. Fenaux, L. Adès, 2015, Blood Cancer Journal.

Identification of JAK2 mutations in canine primary polycythemia.

C. Chomienne, J. Kiladjian, B. Cassinat, 2011, Experimental hematology.

Expression of Preproinsulin-2 Gene Shapes the Immune Response to Preproinsulin in Normal Mice1

C. Boitard, J. Jami, S. Muller, 2004, The Journal of Immunology.

Normal Mice the Immune Response to Preproinsulin in Expression of Preproinsulin-2 Gene Shapes

C. Boitard, J. Jami, S. Muller, 2003 .

Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice.

C. Boitard, J. Jami, S. Muller, 2003, The Journal of clinical investigation.

Modulation of expression of class II histocompatibility antigens by secretion of a cellular inhibitor in K562 leukemic cells

W. Fiers, W. Fiers, C. Boucheix, 1987, European journal of immunology.

Acquisition of tumorigenic potential in the human myoepithelial HBL100 cell line is associated with decreased expression of HLA class I, class II and integrin β3 and increased expression of c‐myc

M. Mareel, C. Jasmin, R. Cassingena, 1989, International journal of cancer.

Implication of a new molecule IK in CD34+ hematopoietic progenitor cell proliferation and differentiation.

M. Le Bousse-Kerdilès, C. Jasmin, D. Clay, 1997, Blood.

Localization of the NRAS:BCL-2 complex determines anti-apoptotic features associated with progressive disease in myelodysplastic syndromes.

P. Merlet, H. Cavé, L. Sarda-Mantel, 2013, Leukemia research.

DNA vaccination with all-trans retinoic acid treatment induces long-term survival and elicits specific immune responses requiring CD4+ and CD8+ T-cell activation in an acute promyelocytic leukemia mouse model.

M. Pla, A. Janin, C. Chomienne, 2010, Blood.

Change in Membrane Fluidity after pinocytosis of a new Cytokine IK on Resting and Activated T cells

Z. Mishal, P. Krief, R. Pereno, 1996 .

Human fibroblasts from cancer patients: lifespan and transformed phenotype in vitro and role of mesenchyme in vivo.

C. Chaponnier, M. Mareel, A. Macieira-Coelho, 1988, Mutation research.

Parallel induction of fibrinolysis and receptors for plasminogen and urokinase by interferon gamma on U937 cells.

J. Soria, C. Soria, O. Bertrand, 1988, Biochemical and biophysical research communications.

The role of growth-factor receptors (excluding IL-2 receptors) in the proliferation and differentiation of normal and leukemic hematopoietic cells.

V. Georgoulias, C. Jasmin, C. Boucheix, 1990, Leukemia research.

Fifteen-year-old girl with systemic lupus erythematosus and unilateral cerebellitis

J. Maytal, A. Eberhard, P. Krief, 2010, Lupus.

High frequency of plasminogen activator secretion by malignant human lymphoid cell lines of T‐cell type origin

J. Soria, C. Soria, A. Houllier, 1988 .

Evaluation of residual disease in human leukemias.

J. Perrot, C. Boucheix, P. Krief, 1985, Revue francaise de transfusion et immuno-hematologie.

An 8-bp deletion in mNOTCH4 intron 10 leads to its retention in mRNA and to synthesis of a truncated protein.

A. Benraiss, I. Laurendeau, C. Boitard, 2005, Experimental cell research.

DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies

V. Mathews, P. Fenaux, N. Tekin, 2015, Oncotarget.

Are interleukin-2 and interleukin-15 tumor promoting factors for human non-hematopoietic cells?

C. Jasmin, E. Rubinstein, F. Indiveri, 1996, European cytokine network.

Method for rapid detection of membrane antigens by immunofluorescence and its application to screening monoclonal antibodies.

J. Perrot, C. Boucheix, P. Krief, 1986, Methods in enzymology.

A new cytokine (IK) down-regulating HLA class II: monoclonal antibodies, cloning and chromosome localization.

C. Jasmin, M. Merck, C. Boucheix, 1994, Oncogene.

Efficacy of Levetiracetam in Children With Epilepsy Younger Than 2 Years of Age

J. Maytal, P. Krief, Li Kan, 2008, Journal of child neurology.

Flow cytometry resonance energy transfer suggests an association between low-affinity interleukin 2 binding sites and HLA class I molecules.

A. Harel-Bellan, W. Farrar, L. Rimsky, 1990, The Biochemical journal.

Proinsulin 2 knockout NOD mice: a model for genetic variation of insulin gene expression in type 1 diabetes.

C. Boitard, J. Jami, P. Krief, 2002, Diabetes.

BCL-2 Inhibitor Venetoclax (ABT-199) and MEK Inhibitor GDC-0973 Synergise to Target AML Progenitors and Overcome Drug Resistance with the Use of PET Scanning in a Mouse Model of HR-MDS to Monitor Response to Treatment

M. Konopleva, M. Andreeff, B. Hosten, 2018, Blood.

Intramedullary air in the high cervical spinal cord after cervical epidural steroid injection

P. Krief, Z. Herschman, B. Parikh, 2008 .

Expression of the interleukin-2 receptor on human fibroblasts and its biological significance.

C. Jasmin, E. Rubinstein, A. Alileche, 1992, International immunology.

Modulation of fibroblast‐induced clot retraction by calcium channel blocking drugs and the monoclonal antibody ALB6

J. Soria, C. Boucheix, B. Azzarone, 1985, Journal of cellular physiology.

Inhibitor (IK) of IFN-γ induced HLA class II antigens expression also inhibits HLA class II constitutive expression in the human Raji B cell line

C. Jasmin, D. Charron, E. Assier, 1997, Oncogene.

BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome

P. Merlet, M. Konopleva, M. Andreeff, 2021, International journal of molecular sciences.